(Press-News.org) DALLAS - April 19, 2021 - Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections, according to the results of two international clinical trials published online today in Diabetes Care. The studies suggest that the once-weekly treatment could provide a convenient alternative to the burden of daily insulin shots for diabetes patients.
Starting and maintaining insulin treatment remain a challenge for millions of patients worldwide with Type 2 diabetes. Fear of injections and the inconvenience and burden of injectable therapy contribute to the barriers against insulin therapy initiation and adherence. The effectiveness and safety of ongoing insulin treatment are also highly dependent on other factors, such as the accuracy of dosages, timing, and glycemic targets. Health care providers believe that reducing the frequency of treatment administration with advances, such as the once-weekly insulin used in these phase 2 trials, may decrease the reluctance to initiate insulin therapy while improving long-term adherence, glucose control, and ultimately, patient well-being.
Insulin, which has been the foundation of diabetes treatment for 100 years, is an effective glucose-lowering agent and is safe when used at the correct dose," says Ildiko Lingvay, M.D., M.P.H., M.S.C.S., a professor of internal medicine and population and data sciences at UT Southwestern. "Insulin treatment is burdensome, requires frequent injections, and continues to carry a certain stigma. The development of an effective and safe insulin that can be administered once a week is a huge advance in the field."
Lingvay, who is a consultant for Novo Nordisk, is the lead author of one of the studies, which involved 205 patients from seven countries (the U.S., Croatia, Germany, Hungary, Poland, Slovakia, and Spain). The clinical trial consisted of a two-week screening period, 16 weeks of treatment, and a five-week follow-up to evaluate three different ways to adjust and optimize the insulin dose and determine which one presented the best balance between effectively lowering glucose while minimizing low-glucose events.
She also is an author of the second study that included 154 patients from five countries (the U.S., Canada, the Czech Republic, Germany, and Italy). This trial followed the same 23-week time frame and evaluated practical aspects of insulin use as well as the best ways to transition from a daily regimen to the new weekly insulin injections. The researchers determined that starting with a higher first dose - called a loading dose - allowed patients to reach their optimal glucose target faster.
"These two studies served as the steppingstones for a large phase 3 clinical trial program that is currently ongoing at UT Southwestern and other sites, which is designed to evaluate the efficacy of once-weekly insulin administration in patients with either Type 1 or Type 2 diabetes," Lingvay says. "A weekly insulin is a game-changer that will decrease the treatment burden for patients while also improving compliance. This treatment will also decrease the burden on those who care for patients with diabetes requiring insulin. For example, for patients who need help injecting, those living in long-term care facilities, and those with memory problems, a once-weekly insulin will facilitate treatment and decrease the burden on the care providers."
INFORMATION:
Novo Nordisk was the sponsor of both studies.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty has received six Nobel Prizes, and includes 23 members of the National Academy of Sciences, 17 members of the National Academy of Medicine, and 13 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,800 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.
Data from a GPS network in Colombia have revealed a shallow and fully locked part on the Caribbean subduction zone in the country that suggests a possible large earthquake and tsunami risk for the northwest region.
The locked patch south of Cartagena city is capable of generating a magnitude 8.0 earthquake every 600 years, said Sindy Lizarazo of Nagoya University in Japan, who presented the study at the Seismological Society of America (SSA)'s 2021 Annual Meeting.
Colombia lies in the middle of a complex tectonic zone, where the Caribbean, Nazca and South American tectonic plates and other smaller tectonic blocks converge. The Caribbean plate ...
Boston College seismologist John Ebel and his colleagues have noted a pattern for some large California earthquakes: magnitude 4 or larger earthquakes occur at a higher rate along a fault in the two decades or more prior to a magnitude 6.7 or larger earthquake on the fault.
The findings prompted Ebel in 2017 to suggest a prospective test. He looked for the California faults that had magnitude 4 or larger earthquakes occurring at a rate higher than 0.5 earthquakes per year from 1997 to 2016. If the pattern holds, the next magnitude 6.7 earthquakes in California are most likely to ...
Eighteen minutes might be all it takes to ensure a full recovery for stroke patients in rural South Carolina.
By changing EMS workflows and incorporating telemedicine techniques, physicians at MUSC Health have partnered with Georgetown Memorial Hospital and Hampton Regional Medical Center to significantly shorten the time between a patient's stroke symptom onset and their treatment, as recently reported in the Journal of Stroke and Cerebrovascular Diseases.
Through MUSC Health's Telestroke Network, emergency medical technicians (EMTs) can video chat with stroke specialists to begin a patient's consult before they even arrive at the hospital. ...
A new study finds a naturally occurring "earthquake gate" that decides which earthquakes are allowed to grow into magnitude 8 or greater.
Sometimes, the "gate" stops earthquakes in the magnitude 7 range, while ones that pass through the gate grow to magnitude 8 or greater, releasing over 32 times as much energy as a magnitude 7.
"An earthquake gate is like someone directing traffic at a one-lane construction zone. Sometimes you pull up and get a green 'go' sign, other times you have a red 'stop' sign until conditions change," said UC Riverside geologist Nicolas Barth.
Researchers learned about this gate while studying New Zealand's Alpine ...
April 19, 2021 - At the current rate of change, it will take more than 200 years for the proportion of women in orthopaedic surgery to reach parity with the overall medical profession, according to a study in Clinical Orthopaedics and Related Research® (CORR®), a publication of The Association of Bone and Joint Surgeons®. The journal is published in the Lippincott portfolio by Wolters Kluwer.
"Substantive changes must be made across all levels of orthopaedic education and leadership to steepen the current curve," concludes the report by Atul F. Kamath, MD, of the Cleveland Clinic Foundation and colleagues. "Our findings support the need for changes in medical schools, orthopaedic residency ...
Inside your body, cell movement plays a crucial role in many significant biological processes, including wound healing, immune responses and the potential spread of cancer.
"Most people don't die from having a primary tumor," said Kolade Adebowale, a graduate student in chemical engineering, and a member of the Chemical Biology Interface (CBI) graduate program in Chemistry, Engineering & Medicine for Human Health (ChEM-H) at Stanford University. "The problem is when cancer cells from the tumor acquire the ability to metastasize or move to different parts ...
RIVERSIDE, Calif. -- A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how they deliver care.
"Since the pandemic began, more than 95% of our survey respondents reported using telehealth platforms to provide care for their patients," said Dr. Elizabeth Morrison-Banks, a health sciences clinical professor of neurology in the School of Medicine at the University of California, Riverside, who led the survey reported in the journal Multiple Sclerosis and Related Disorders. "Approximately one half of the respondents were MS specialist neurologists, four out of five of whom indicated that COVID-19 had changed ...
Airbnb hosts in college towns increase their listing prices much more than hotels when there are home football games against rival teams. Hosts experience a 78 percent reduction in rental income by listing prices too high, according to a new study by the University of California San Diego’s Rady School of Management.
The paper, to be published in Real Estate Economics, investigates whether households set listing prices to maximize rental income.
“Airbnb hosts in college towns are individuals, not corporations and are more susceptible to biases that lead to sub-optimal pricing,” said co-author Joseph Engelberg, professor of finance and accounting at the Rady School. “In ...
BOSTON - At the end of 2020, experts led by allergists at Massachusetts General Hospital (MGH) examined all information related to possible allergic reactions to COVID-19 vaccinations. Now the team has published updated insights based on their experience overseeing more than 65,000 employees who have become fully vaccinated since that time. The group's latest findings are published in the Journal of Allergy and Clinical Immunology: In Practice.
"Our main goal is to enable as many individuals as possible to receive a COVID-19 vaccine safely and avoid unnecessary vaccine hesitancy due to a lack of knowledge around allergic reactions to vaccines," says lead author Aleena Banerji, MD, clinical director of the Allergy and Clinical Immunology Unit at MGH.
In addition to updated guidance ...
Two studies led by Baylor College of Medicine shed new light on the unanswered question of why estrogen receptor-positive (ER+) breast cancer sometimes grows back in the bone and spreads to other tissues despite effective endocrine therapies directed at ER.
Working with animal models that include patient tumor samples, the team discovered that the bone microenvironment surrounding ER+ breast cancer cells reduced ER expression in these cells, leading to resistance to ER-targeting endocrine therapy (findings published in the journal Developmental Cell DOI: 10.1016/j.devcel.2021.03.008). Furthermore, the bone microenvironment triggered reprogramming of the cancer cells that promoted their ability to metastasize or spread to other tissues (findings published in Cell DOI: 10.1016/j.cell.2021.03.011 ...
